Delivery Order SPE2DB22D7065-SPE2DB25FH2WM
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Menquadfi vial 0.5ml pharmaceutical products. This firm fixed-price delivery order, valued at $5,085.08, is due for completion by September 19, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award was made on a competitive basis without set-aside provisions, reflecting AmerisourceBergen's demonstrated capability to meet federal...
- The Defense Logistics Agency awarded a delivery order valued at $2,905.80 to AmerisourceBergen Drug Corp for MENQUADFI vial 0.5ML on September 11, 2025, with completion targeted for September 12, 2025. This is a firm fixed-price contract with no set-aside designation, competitively awarded to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $29,333.15 to AmerisourceBergen Drug Corp for Menquadfi vial 0.5ML on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award was competitively bid with no set-aside designation and will...
- The Defense Logistics Agency awarded a delivery order valued at $2,179.32 to AmerisourceBergen Drug Corp for MENQUADFI VIAL 0.5ML, a pharmaceutical product, with a completion date of August 20, 2025. This is a firm fixed-price delivery order with no set-aside designation, reflecting AmerisourceBergen's capability to compete successfully in open federal procurement. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $65,228.60 to AmerisourceBergen Drug Corp for the supply of Menquadfi vials (0.5ML) with an ultimate completion date of September 17, 2025. This non-set-aside contract was competitively awarded and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, is...
- The Defense Logistics Agency awarded a delivery order valued at $18,365.68 to AmerisourceBergen Drug Corp for the supply of Menquadfi vials (0.5ML) on September 12, 2025, with an ultimate completion date of September 15, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $1,452.90 to AmerisourceBergen Drug Corp for MENQUADFI VIAL 0.5ML on August 20, 2025, with an ultimate completion date of August 21, 2025. This competitively awarded, firm fixed-price contract was issued with no set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order valued at $1,452.88 to AmerisourceBergen Drug Corp for the supply of Menquadfi vial 0.5ML on June 2, 2025, with an ultimate completion date of June 3, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and is to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $3,656.00 to AmerisourceBergen Drug Corp for the supply of Menquadfi vials (0.5mL) on August 18, 2025, with a completion date of August 19, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is classified as a child contract under AmerisourceBergen's larger federal contract vehicle. The place of performance is listed as Conshohocken, Pennsylvania, which serves as the company's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $4,358.64 to AmerisourceBergen Drug Corp for MENQUADFI Vial 0.5ML on June 18, 2025, with an ultimate completion date of June 20, 2025. This firm fixed price delivery order represents a competitive award with no set-aside designation and is performed at the contractor's location in Conshohocken, Pennsylvania. The order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a...
- SPE2DB22D7065Indefinite Delivery Contract
- SPE2DB22D7065-SPE2DB25FH2WMDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,905.80 to AmerisourceBergen Drug Corp for Menquadfi vial 0.5mL pharmaceutical products on June 5, 2025, with completion targeted for June 6, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, was selected through open competition to deliver this specialized medical supply. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime contract running through December 2026 that serves as a comprehensive global pharmaceutical support vehicle. Through this IDC, the company supplies a broad range of pharmaceutical products and medical commodities to support military healthcare programs and federal medical supply chain needs across multiple therapeutic domains, serving customers including the Defense Health Agency and U.S. Coast Guard. The contract exemplifies the company's established capability to fulfill federal medical procurement requirements through competitive federal contracting.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 6/5/25 |